ASCO: NSCLC Tumor Profiling and Biomarker-Guided Therapy are Feasible
A massive French database study shows that genetic tumor profiling in patients with non–small-cell lung cancer (NSCLC) is feasible, and is already helping physicians guide treatment in many patients, according to results presented at the American Society of Clinical Oncology annual meeting.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Study